Compare · ROP vs TEM
ROP vs TEM
Side-by-side comparison of Roper Technologies Inc. (ROP) and Tempus AI Inc. (TEM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ROP and TEM operate in Computer Software: Programming Data Processing (Technology), so they compete in similar markets.
- ROP is the larger of the two at $45.94B, about 5.5x TEM ($8.34B).
- TEM has been more active in the news (33 items in the past 4 weeks vs 13 for ROP).
- Both have 25 recent analyst ratings on file.
- Company
- Roper Technologies Inc.
- Tempus AI Inc.
- Price
- $333.68+0.39%
- $48.56+4.72%
- Market cap
- $45.94B
- $8.34B
- 1M return
- -5.31%
- -
- 1Y return
- -41.84%
- -
- Industry
- Computer Software: Programming Data Processing
- Computer Software: Programming Data Processing
- Exchange
- NYSE
- NASDAQ
- IPO
- 1992
- 2024
- News (4w)
- 13
- 33
- Recent ratings
- 25
- 25
Roper Technologies Inc.
Roper Technologies, Inc. designs and develops software, and engineered products and solutions. The company offers management, campus solutions, laboratory information management, enterprise management, information solutions, transportation management, financial and compliance management, cloud-based financial analytics and performance management, and diagnostic and laboratory information system software; and software, services, and technologies for foodservice operations. It also provides cloud-based data, collaboration, and estimating automation software; electronic marketplace; visual effects and 3D content software; wireless sensor network and solutions; cloud-based software solutions; supply chain software; health care service and software; RFID card readers; data analytics and information; pharmacy software; and toll system and products, transaction and violation processing services, and intelligent traffic systems. In addition, the company offers precision rubber and polymer testing instruments, and data analysis software; ultrasound accessories; radiotherapy solutions; testing and analyzing plastic solutions; dispensers and metering pumps; control valves; precision weighing equipment; automated surgical scrub and linen dispensing equipment; water meters; optical and electromagnetic measurement systems; automated leak detection equipment; medical devices; products and services for water and gas utilities; and equipment and consumables. It also provides temperature control and emergency shutoff valves; turbomachinery control hardware, software, and services; specialized pumps; flow meter calibrators and controllers; vibration monitoring systems and controls; analytical instrument; drilling power section; pressure and level sensors; and non-destructive testing equipment. The company was formerly known as Roper Industries, Inc. and changed its name to Roper Technologies, Inc. in April 2015. The company was incorporated in 1981 and is based in Sarasota, Florida.
Latest ROP
- Director Esteves Irene M was granted 1,191 shares, increasing direct ownership by 31% to 5,051 units (SEC Form 4)
- Director Archambeau Shellye L was granted 1,191 shares, increasing direct ownership by 14% to 9,477 units (SEC Form 4)
- Director Joyce Thomas Patrick Jr was granted 1,191 shares, increasing direct ownership by 31% to 5,051 units (SEC Form 4)
- Director Brinkley Amy Woods was granted 1,191 shares, increasing direct ownership by 7% to 19,375 units (SEC Form 4)
- Director Johnson Robert D was granted 1,191 shares, increasing direct ownership by 25% to 5,885 units (SEC Form 4)
- Director Murphy John Francis was granted 1,191 shares, increasing direct ownership by 80% to 2,687 units (SEC Form 4)
- Director Thatcher Laura G was granted 1,191 shares, increasing direct ownership by 6% to 22,115 units (SEC Form 4)
- Director Wallman Richard F was granted 1,191 shares, increasing direct ownership by 9% to 13,857 units (SEC Form 4)
- SEC Form S-8 filed by Roper Technologies Inc.
- SEC Form 8-K filed by Roper Technologies Inc.
Latest TEM
- Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
- Director Epstein David R sold $12,350 worth of shares (250 units at $49.40) as part of a pre-agreed trading plan, decreasing direct ownership by 0.79% to 31,464 units (SEC Form 4)
- Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members
- Wolfe Research resumed coverage on Tempus AI
- Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH
- Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development
- Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community
- Tempus Introduces 'Preview': Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results
- CEO and Chairman Lefkofsky Eric P sold $7,763,312 worth of shares (166,250 units at $46.70) as part of a pre-agreed trading plan (SEC Form 4)
- Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncology